By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic this week reported first-quarter revenue growth of 8 percent, with instrument sales up 12 percent year over year.

The Omaha, Neb.-based firm took in total revenues of $5.4 million for the three-month period ended March 31, compared to $5 million for the first quarter of 2009.

Transgenomic cut its net loss by nearly two-thirds to $324,000, or $.01 per share, from $953,000, or $.02 per share, for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.